Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals

Alzheimer’s disease biomarkers are primarily evaluated through MRI, PET and CSF methods in order to diagnose and monitor disease. Recently, advances in the assessment of blood-based biomarkers have shown promise for simple, inexpensive, accessible and minimally invasive tools with diagnostic and pro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Brain Commun
Prif Awduron: Lussier, Firoza Z, Benedet, Andréa L, Therriault, Joseph, Pascoal, Tharick A, Tissot, Cécile, Chamoun, Mira, Mathotaarachchi, Sulantha, Savard, Melissa, Ashton, Nicholas J, Karikari, Thomas K, Rodriguez, Juan Lantero, Snellman, Anniina, Bezgin, Gleb, Kang, Min Su, Fernandez Arias, Jaime, Wang, Yi-Ting, Gauthier, Serge, Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2021
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088291/
https://ncbi.nlm.nih.gov/pubmed/33959711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcab073
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg